glp 1 clinical trials recruiting GLP-1a: Going beyond Traditional Use clinical trials for glp-1 obesity

Sleep is severely disrupted

These medications slow gastric emptying and reduce appetite, which can inadvertently decrease fluid intake while increasing the risk of dehydration through gastrointestinal symptoms like nausea, vomiting, and diarrhea

When compared to those taking a placebo and with all participants eating a standardized breakfast, people taking semaglutide ate 24% less overall and approximately 35% less during their lunch and evening meals

Safe discontinuation requires GP consultation to assess diabetes control, arrange monitoring, and establish alternative treatment if needed

And although side effects can occur when taking GLP1 drops , their frequency and severity are usually low

While some preclinical studies suggest GLP-1 receptor agonists may have anti-inflammatory properties, it is important to emphasise that there is no clinical evidence demonstrating benefit in fibromyalgia patients